Invitae (Invitae) Days Inventory : 23.56 (As of Sep. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Invitae Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Invitae's Average Total Inventories for the three months ended in Sep. 2023 was $21.2 Mil. Invitae's Cost of Goods Sold for the three months ended in Sep. 2023 was $82.2 Mil. Hence, Invitae's Days Inventory for the three months ended in Sep. 2023 was 23.56.

The historical rank and industry rank for Invitae's Days Inventory or its related term are showing as below:

NVTAQ' s Days Inventory Range Over the Past 10 Years
Min: 20.55 Med: 31.13 Max: 35.6
Current: 25.34

During the past 11 years, Invitae's highest Days Inventory was 35.60. The lowest was 20.55. And the median was 31.13.

NVTAQ's Days Inventory is ranked better than
81.25% of 192 companies
in the Medical Diagnostics & Research industry
Industry Median: 65.03 vs NVTAQ: 25.34

Invitae's Days Inventory declined from Sep. 2022 (30.81) to Sep. 2023 (23.56).

Inventory Turnover measures how fast the company turns over its inventory within a year. Invitae's Inventory Turnover for the three months ended in Sep. 2023 was 3.87.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Invitae's Inventory-to-Revenue for the three months ended in Sep. 2023 was 0.18.

Invitae Days Inventory Historical Data

The historical data trend for Invitae's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invitae Days Inventory Chart

Invitae Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Inventory

Get a 7-Day Free Trial

20.55

35.60

34.31

27.95

Invitae Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Days Inventory	Get a 7-Day Free Trial															30.81	29.63	25.51	20.80	23.56

Competitive Comparison of Invitae's Days Inventory

For the Diagnostics & Research subindustry, Invitae's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Invitae's Days Inventory Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Invitae's Days Inventory distribution charts can be found below:

* The bar in red indicates where Invitae's Days Inventory falls into.

Invitae Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Invitae's Days Inventory for the fiscal year that ended in Dec. 2022 is calculated as

	Days Inventory (A: Dec. 2022 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2021 )	+	Total Inventories (A: Dec. 2022 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2022 )	*	Days in Period
=	( (33.516	+	30.386)	/	2 )	/	417.256	*	365
=	31.951					/	417.256	*	365
=	27.95

Invitae's Days Inventory for the quarter that ended in Sep. 2023 is calculated as:

	Days Inventory (Q: Sep. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Jun. 2023 )	+	Total Inventories (Q: Sep. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2023 )	*	Days in Period
=	( (20.814	+	21.627)	/	2 )	/	82.186	*	365 / 4
=	21.2205					/	82.186	*	365 / 4
=	23.56

Invitae (OTCPK:NVTAQ) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Invitae's Inventory Turnover for the three months ended in Sep. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	82.186	/	21.2205
	=	3.87

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Invitae's Inventory to Revenue for the three months ended in Sep. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	21.2205	/	121.241
	=	0.18

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Invitae Days Inventory Related Terms

Thank you for viewing the detailed overview of Invitae's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Invitae (Invitae) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Invitae Corp (OTCPK:NVTAQ) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

NVTA:Mexico IV8:Germany

Address

1400 16th Street, San Francisco, CA, USA, 94103

Website

https://www.invitae.com

Invitae Corp operates as a genetic information company in diagnostic and research industry. The company's tests include multiple genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders, metabolic disorders and other hereditary conditions.

Executives

Ana J. Schrank	officer: Chief Financial Officer	1400 16TH STREET, SAN FRANCISCO CA 94103
Robert M. Guigley	officer: Chief Commercial Officer	1400 16TH STREET, SAN FRANCISCO CA 94103
Robert Iv Dickey	officer: See Remarks	320 WEST MERMAID LANE, PHILADELPHIA PA 19118
Jeff Parsons	officer: See remarks	2575 AUGUSTINE DRIVE, SANTA CLARA CA 95054
Robert L Nussbaum	officer: Chief Medical Officer	458 BRANNAN STREET, SAN FRANCISCO CA 94107
Thomas Brida	officer: General Counsel	458 BRANNAN STREET, SAN FRANCISCO CA 94107
Robert F. Werner	officer: Chief Accounting Officer	2500 FABER PLACE, PALO ALTO CA 94303
Yafei Wen	officer: Chief Financial Officer	1400 16TH STREET, SAN FRANCISCO CA 94103
Kenneth D. Knight	officer: Chief Operating Officer	1400 16TH STREET, SAN FRANCISCO CA 94103
William H Osborne	director	1415 WEST 22ND STREET, SUITE 1100, OAK BROOK IL 60523
Sean E George	director, officer: CEO	458 BRANNAN STREET, SAN FRANCISCO CA 94107
Shelly D Guyer	officer: Chief Financial Officer	1025 GREEN STREET, SAN FRANCISCO CA 94133
Katherine Stueland	officer: Chief Commercial Officer	458 BRANNAN STREET, SAN FRANCISCO CA 94107
Geoffrey Crouse	director	3130 GATEWAY DRIVE, P O BOX 5625, NORCROSS GA 30091-5625
Jason W. Myers	director, other: President, Oncology	C/O ARCHERDX, INC., 2477 55TH STREET, SUITE 202, BOULDER CO 80301